Mortality Benefit with Prasugrel in the TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk-Adjusted Retrospective Data Analysis

OBJECTIVES: The objective of this study is to characterize the bleeding, transfusion and other outcomes of patients related to the timing of prasugrel or clopidogrel withdrawal prior to coronary artery bypass grafting (CABG). BACKGROUND: There is little evidence to guide clinical decision making reg...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Smith, Peter K, Goodnough, Lawrence T, Levy, Jerrold H, Poston, Robert S, Short, Mary A, Weerakkody, Govinda J, LeNarz, LeRoy A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3407327/
https://ncbi.nlm.nih.gov/pubmed/22633653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2012.03.030
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia